HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma.

AuthorsCatherine M Bollard, Stephen Gottschalk, M Helen Huls, Ann M Leen, Adrian P Gee, Cliona M Rooney
JournalCytotherapy (Cytotherapy) Vol. 13 Issue 5 Pg. 518-22 (May 2011) ISSN: 1477-2566 [Electronic] England
PMID21361747 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • EBV-associated membrane antigen, Epstein-Barr virus
  • Viral Matrix Proteins
Topics
  • Antigen-Presenting Cells (immunology)
  • Cell Culture Techniques
  • Cell Line, Tumor
  • Cell Separation (methods)
  • Epstein-Barr Virus Infections (complications, therapy)
  • Herpesvirus 4, Human (immunology)
  • Humans
  • Immunotherapy, Adoptive (methods)
  • Lymphoma (therapy, virology)
  • T-Lymphocytes, Cytotoxic (immunology, transplantation)
  • Transduction, Genetic
  • Viral Matrix Proteins (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: